

Advanced Therapeutics Glucofit Rx-Blood Sugar
Nature's Plus
Overview
This product contains Glucofit(TM), which is likely oat beta-glucan, and corosolic acid, both of which have shown potential for supporting healthy blood sugar levels. However, the amount of Glucofit(TM) is minimal, and the advertised 480mcg of corosolic acid per capsule contradicts the stated 2.67mg of glucofit listed in the supplement facts, creating concern about the accuracy of the label and leading some to believe the corosolic acid amount is overstated. The declared amount of 2.67mg ‘Glucofit(TM)’ is far below the clinically relevant doses for oat beta-glucan, which is typically 3-10g per day.
The Good
Contains corosolic acid, which may support healthy blood sugar levels
Includes oat beta-glucan which has some evidence supporting healthy blood sugar levels
The Bad
Low dose of active ingredient
Insufficient evidence for stated use
Lack of studies on specific Glucofit(TM) formulation
Is it for you?
Best For: Individuals seeking to support healthy blood sugar levels
Skip If: You are taking blood sugar-lowering medications or have diabetes without consulting a healthcare provider.
Ingredients Analysis
Glucofit(Tm)
2.67 mgHow to Use
Typically taken daily with food, following dosage instructions on the product label once available.
Daily
Morning
With food
Who Should Use This
Best For:
Recommended Articles

Top Immune Support Ingredients: What Works?
Vitamin D, zinc, and echinacea are key ingredients in immune support supplements, backed by scientific evidence.

Best Curcumin for Osteoarthritis: Bioavailability Guide
Curcumin formulations with enhanced bioavailability, such as those combined with lecithin, are most effective for treating osteoarthritis.

Optimal Berberine Dosing Guide
Optimal berberine intake involves 500-1500 mg/day, split 2-3 times, ideally 30-60 minutes before meals, tailored to individual needs.

Pharma-Grade Berberine for Weight Loss: 2025 US Outlook
Pharmaceutical-grade berberine shows promise for weight loss, with increasing demand and availability expected by 2025 in the US.